YILDIRIM, M. E. Et Al. 2022. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.. 2022 ASCO Gastrointestinal Cancers Symposium (GICS) , (San Francisco, California, United States Of America).

YILDIRIM, M. E., KARACA, M., ARTAÇ, M., ÇİÇİN, İ., GEREDELİ, Ç., ALACACIOĞLU, A., ... TANRIKULU ŞİMŞEK, E.(2022). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC. . 2022 ASCO Gastrointestinal Cancers Symposium (GICS), San Francisco, California, United States Of America

YILDIRIM, MAHMUT Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.," 2022 ASCO Gastrointestinal Cancers Symposium (GICS), San Francisco, California, United States Of America, 2022

YILDIRIM, MAHMUT E. Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.." 2022 ASCO Gastrointestinal Cancers Symposium (GICS) , San Francisco, California, United States Of America, 2022

YILDIRIM, M. E. Et Al. (2022) . "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.." 2022 ASCO Gastrointestinal Cancers Symposium (GICS) , San Francisco, California, United States Of America.

@conferencepaper{conferencepaper, author={MAHMUT EMRE YILDIRIM Et Al. }, title={Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wi̇ld-type patients treated with biologics second-line mCRC.}, congress name={2022 ASCO Gastrointestinal Cancers Symposium (GICS)}, city={San Francisco, California}, country={United States Of America}, year={2022}}